FindTrial
Sign In

Standardization Of Ashwakanchuki Rasa And Its Clinical Efficacy In The Management Of Tamaka Shwasa(Bronchial Asthma)

Scientific evaluation of Ashwakachuki Rasa with special reference to shwasa roga (Bronchial Asthama ) (pharmaceutical, analytical and clinical study)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/01/007635
Enrollment
30
Registered
2017-01-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Bronchial Asthama

Interventions

Intervention1: Ashwakanchuki Rasa with bhringraja swarasa Bhavna: 125 mg BD with Ardraka Swarasa for 28 days Control Intervention1: Ashwakanchuki Rasa with additional Ardraka swarasa bhavna: 125 BD wi

Sponsors

JS Ayurveda Mahavidhyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Mild persistent case of Asthma (as per WHO gina guidelines) with duration of more than 6 months.

Exclusion criteria

Exclusion criteria: Patient having pneumonia, lung collapse, pneumothorax, parenchymal lung disease, lower respiratory tract infection, pleural effusion, lung cancer, lung abscess and other complicated condition. • HIV positive case

Design outcomes

Primary

MeasureTime frame
the patients will be followed for 4 week.Timepoint: 4 weeks—

Secondary

MeasureTime frame
Patients will be reviewed after 15 days of completion of the treatment.Timepoint: 15 days—

Countries

India

Contacts

Public Contactdr Vidhi M Shukla

J.S.Ayurveda college, Nadiad, 387001

ayurvednadiad@gmail.com02682520724

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026